Benmoxin
From Wikipedia, the free encyclopedia
Template:Short description Template:Short description Page Template:Infobox drug/styles.css has no content.
Page Module:Infobox/styles.css has no content.
Benmoxin (trade names Neuralex, Nerusil), also known as mebamoxine, is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine class.[1][2] It was synthesized in 1967 and was subsequently used as an antidepressant in Europe, but is now no longer marketed.[1][2]
See also
References
Page Template:Reflist/styles.css has no content.
- ^ a b Page Module:Citation/CS1/styles.css has no content.Ganellin CR, Triggle DJ (1996). Dictionary of Pharmacological Agents. Vol. 1–2. Chapman & Hall. p. 229. ISBN 0-9630096-0-5.
- ^ a b Page Module:Citation/CS1/styles.css has no content.Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. ISBN 3-88763-075-0.
Lua error in package.lua at line 80: module 'Module:Navbox/configuration' not found. Template:Monoamine metabolism modulators Lua error in package.lua at line 80: module 'Module:Navbox/configuration' not found.